152 related articles for article (PubMed ID: 25340261)
21. Design, characterization and skin permeating potential of Fluocinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis.
Pradhan M; Singh D; Murthy SN; Singh MR
Steroids; 2015 Sep; 101():56-63. PubMed ID: 26049018
[TBL] [Abstract][Full Text] [Related]
22. Formulation design and in vivo antimalarial evaluation of lipid-based drug delivery systems for oral delivery of β-arteether.
Memvanga PB; Préat V
Eur J Pharm Biopharm; 2012 Sep; 82(1):112-9. PubMed ID: 22609572
[TBL] [Abstract][Full Text] [Related]
23. Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: Nanoject.
Joshi M; Pathak S; Sharma S; Patravale V
Int J Pharm; 2008 Nov; 364(1):119-26. PubMed ID: 18765274
[TBL] [Abstract][Full Text] [Related]
24. Improved antimalarial activity of caprol-based nanostructured lipid carriers encapsulating artemether-lumefantrine for oral administration.
Akpa PA; Ugwuoke JA; Attama AA; Ugwu CN; Ezeibe EN; Momoh MA; Echezona AC; Kenechukwu FC
Afr Health Sci; 2020 Dec; 20(4):1679-1697. PubMed ID: 34394228
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of Nanostructured Lipid Carriers Loaded Chitosan/ Carbopol Hybrid Nanocomposite Gel for Oral Delivery of Artemether and Curcumin.
Kumar A; Behl T; Uniyal T; Chadha S
Pharm Nanotechnol; 2020; 8(5):418-432. PubMed ID: 32895049
[TBL] [Abstract][Full Text] [Related]
26. Optimisation of chloroquine phosphate loaded nanostructured lipid carriers using Box-Behnken design and its antimalarial efficacy.
Baruah UK; Gowthamarajan K; Ravisankar V; Karri VVSR; Simhadri PK; Singh V
J Drug Target; 2018 Aug; 26(7):576-591. PubMed ID: 29057679
[TBL] [Abstract][Full Text] [Related]
27. Design, characterization and antimalarial efficacy of PEGylated galactosylated nano lipid carriers of primaquine phosphate.
Baruah UK; Gowthamarajan K; Ravisankar V; Karri VVSR; Simhadri PK; Singh V; Babu PP
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1809-1829. PubMed ID: 29087218
[TBL] [Abstract][Full Text] [Related]
28. Solid microemulsion preconcentrate (NanOsorb) of artemether for effective treatment of malaria.
Joshi M; Pathak S; Sharma S; Patravale V
Int J Pharm; 2008 Oct; 362(1-2):172-8. PubMed ID: 18611435
[TBL] [Abstract][Full Text] [Related]
29. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
Das S; Ng WK; Tan RB
Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics study of arteether loaded solid lipid nanoparticles: an improved oral bioavailability in rats.
Dwivedi P; Khatik R; Khandelwal K; Taneja I; Raju KS; Wahajuddin ; Paliwal SK; Dwivedi AK; Mishra PR
Int J Pharm; 2014 May; 466(1-2):321-7. PubMed ID: 24657144
[TBL] [Abstract][Full Text] [Related]
31. Docetaxel-nicotinamide complex-loaded nanostructured lipid carriers for transdermal delivery.
Fan X; Chen J; Shen Q
Int J Pharm; 2013 Dec; 458(2):296-304. PubMed ID: 24177313
[TBL] [Abstract][Full Text] [Related]
32. A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers.
Pinto MF; Moura CC; Nunes C; Segundo MA; Costa Lima SA; Reis S
Int J Pharm; 2014 Dec; 477(1-2):519-26. PubMed ID: 25445970
[TBL] [Abstract][Full Text] [Related]
33. Biocompatible Lipid Nanoparticles as Carriers To Improve Curcumin Efficacy in Ovarian Cancer Treatment.
Bondì ML; Emma MR; Botto C; Augello G; Azzolina A; Di Gaudio F; Craparo EF; Cavallaro G; Bachvarov D; Cervello M
J Agric Food Chem; 2017 Feb; 65(7):1342-1352. PubMed ID: 28111949
[TBL] [Abstract][Full Text] [Related]
34. Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake.
Tiwari R; Pathak K
Int J Pharm; 2011 Aug; 415(1-2):232-43. PubMed ID: 21640809
[TBL] [Abstract][Full Text] [Related]
35. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol.
Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X
J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044
[TBL] [Abstract][Full Text] [Related]
36. Development of Novel Solid Nanostructured Lipid Carriers for Bioavailability Enhancement Using a Quality by Design Approach.
Bajwa N; Mahal S; Naryal S; Singh PA; Baldi A
AAPS PharmSciTech; 2022 Sep; 23(7):253. PubMed ID: 36109467
[TBL] [Abstract][Full Text] [Related]
37. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry.
Castelli F; Puglia C; Sarpietro MG; Rizza L; Bonina F
Int J Pharm; 2005 Nov; 304(1-2):231-8. PubMed ID: 16188405
[TBL] [Abstract][Full Text] [Related]
38. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability.
Zhuang CY; Li N; Wang M; Zhang XN; Pan WS; Peng JJ; Pan YS; Tang X
Int J Pharm; 2010 Jul; 394(1-2):179-85. PubMed ID: 20471464
[TBL] [Abstract][Full Text] [Related]
39. A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine.
Lin C; Chen F; Ye T; Zhang L; Zhang W; Liu D; Xiong W; Yang X; Pan W
Int J Pharm; 2014 Apr; 465(1-2):90-6. PubMed ID: 24530388
[TBL] [Abstract][Full Text] [Related]
40. Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus.
Pople PV; Singh KK
Eur J Pharm Biopharm; 2011 Sep; 79(1):82-94. PubMed ID: 21447390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]